13F-HR filed by Exome Asset Management LLC
Exome Asset Management LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 52 holding rows worth $162,102,170.
- Accession
- 0001420506-26-001714
- Filer
- CIK 2011932
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 52 entries on the cover page, a total value of $162,102,170 stated on the cover page (in dollars after the unit check, H1), rows summing to $162,102,170 with VALUE read as dollars as filed, 13F file number 028-23951. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 67,500 | $10,127,025 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 27,205 | $9,107,962 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 164,915 | $9,060,430 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 210,523 | $8,147,240 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 88,177 | $6,991,554 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 5,492 | $6,587,270 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 46,878 | $6,246,962 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 204,418 | $5,752,323 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 60,056 | $5,116,171 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 100,203 | $5,085,302 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 97,276 | $4,174,113 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 9,612 | $3,995,036 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 102,629 | $3,934,796 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 13,800 | $3,746,010 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 81,056 | $3,733,439 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 32,209 | $3,576,165 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 114,692 | $3,422,409 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 137,115 | $3,318,183 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 166,493 | $3,241,619 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 61,336 | $3,213,700 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 39,224 | $3,127,330 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 5,410 | $2,931,300 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 19,862 | $2,775,913 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 32,214 | $2,625,763 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 70,500 | $2,616,255 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 127,769 | $2,299,842 | dollars as filed | |
| ASTRAZENECA PLC ORD | G0593M107 | ADR | 12,045 | $2,254,128 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 48,347 | $2,063,450 | dollars as filed | |
| ADAGENE INC | 005329107 | CMN | 488,293 | $2,050,831 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 6,300 | $1,989,225 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 4,908 | $1,951,813 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 47,861 | $1,867,058 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 181,588 | $1,783,194 | dollars as filed | |
| EQUILLIUM INC | 29446K106 | COM | 552,956 | $1,769,459 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 6,573 | $1,753,151 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 184,914 | $1,734,493 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 460,067 | $1,725,251 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 429,041 | $1,638,937 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 22,417 | $1,564,931 | dollars as filed | |
| CLEARPOINT NEURO INC | 18507C103 | COM | 83,636 | $1,492,066 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 13,873 | $1,479,139 | dollars as filed | |
| CARIS LIFE SCIENCES INC | 142152107 | COMMON STOCK | 78,180 | $1,393,168 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 18,359 | $1,367,378 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 52,443 | $1,331,003 | dollars as filed | |
| NOVABRIDGE BIOSCIENCES | 44975P103 | CMN | 576,960 | $1,125,072 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 13,100 | $1,124,111 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 47,531 | $889,305 | dollars as filed | |
| GERON CORP | 374163103 | COM | 624,046 | $798,779 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 10,110 | $709,722 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 276,165 | $604,801 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 40,361 | $446,796 | dollars as filed | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 50,166 | $240,797 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-001714 | this filing | 2026-08-14 | acceptance time not in the bulk data set |